SCHEMBL249977

SCHEMBL249977

CN(C)C1(c2cccs2)CCC(N)CC1.O=C(O)CCCC(=O)NCc1cccc(Cl)c1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
THRB P10828 2/20 0.40
TP53 P04637 1/20 0.40
MAPT P10636 1/20 0.40
ALDH1A1 P00352 3/20 0.38
KMT2A Q03164 2/20 0.38
NOS2 P35228 1/20 0.38
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
P2RX7 Q99572 1/20 0.37
HPGD P15428 1/20 0.36
FFAR2 O15552 2/20 0.36
EPHX2 P34913 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL249994 0.90 NPC1 (0.45) SMN1; SMN2NPC1MAPTKMT2ANOS2
SCHEMBL248648 0.88 NPC1 (0.38) SMN1; SMN2NPC1RAB9AKMT2AP2RX7
SCHEMBL248430 0.81 THRB (0.37) SMN1; SMN2THRBMAPTALDH1A1KMT2A
SCHEMBL250561 0.79 HDAC3 (0.39) SMN1; SMN2KMT2A
SCHEMBL250033 0.78 OPRL1 (0.42) NPC1RAB9AMAPT
SCHEMBL207133 0.78 ALDH1A1 (0.50) SMN1; SMN2NPC1RAB9ATHRBMAPT
SCHEMBL249993 0.77 NPC1 (0.43) NPC1RAB9AALDH1A1KMT2A
SCHEMBL251283 0.77 OPRM1 (0.44) NPC1RAB9AALDH1A1HPGDEPHX2
SCHEMBL4074080 0.77 OPRM1 (0.51) NPC1RAB9AEPHX2
SCHEMBL251293 0.76 ENPP2 (0.42) SMN1; SMN2NPC1RAB9ATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088763-B2 e.g. N-[1-(2,6-dichloro-benzyl)-pyrrolidin-3-yl]-N'-[4-dimethylamino-4-(4-methyl-benzyl)-cyclohexyl]-succinamide; noradrenaline and serotonin reuptake ihibitor; opioid ORL-1 receptor ligand; analgesic, antidepressant, anxiolytic agent, neurodegenerative diseases GRUENENTHAL GMBH (DE) 2012-01-03 US disclosed